Evidence map›Paper›PMID 27927870›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

Insidious Risk of Severe Mycobacterium chimaera Infection in Cardiac Surgery Patients.

Meera Chand, Theresa Lamagni, Katharina Kranzer, Jessica Hedge, Ginny Moore, Simon Parks, Samuel Collins, Carlos Del Ojo Elias, Nada Ahmed, Tim Brown and 31 more

Erratum issuedAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Article
  4. The Global Outbreak ofPathogens (Basel, Switzerland) · 2025
    Article
  5. 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery.Interdisciplinary cardiovascular and thoracic surgery · 2025
    Article
  6. 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2025
    Article
  7. Article
  8. The State-of-the-Art ofHealthcare (Basel, Switzerland) · 2024
    Review
  9. Mycobacterial Biofilm: Mechanisms, Clinical Problems, and Treatments.International journal of molecular sciences · 2024
    Review
  10. Safety and Efficacy of Extracorporeal Membrane Oxygenation Heating Units.World journal for pediatric & congenital heart surgery · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. An Unfavorable Outcome ofDiagnostics (Basel, Switzerland) · 2022
    Article
  15. Review
  16. Article
  17. Pathogens (Basel, Switzerland) · 2021
    Article
  18. Review
  19. Open forum infectious diseases · 2021
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

41 authors.

Meera ChandNational Infection Service, Public Health England.
Theresa LamagniNational Infection Service, Public Health England.
Katharina KranzerNational Infection Service, Public Health England.
Jessica HedgeNuffield Department of Medicine, University of Oxford.
Ginny MooreNational Infection Service, Public Health England.
Simon ParksNational Infection Service, Public Health England.
Samuel CollinsNational Infection Service, Public Health England.
Carlos Del Ojo EliasNuffield Department of Medicine, University of Oxford.
Nada AhmedNational Infection Service, Public Health England.
Tim BrownNational Infection Service, Public Health England.
E Grace SmithNational Infection Service, Public Health England.
Peter HoffmanNational Infection Service, Public Health England.
Peter KirwanNational Infection Service, Public Health England.
Brendan MasonPublic Health Wales NHS Trust, Cardiff.
Alison Smith-PalmerVaccine Preventable Diseases, Health Protection Scotland, Glasgow, and.
Philip VealHealth Protection Service, Public Health Agency Northern Ireland, Belfast, United Kingdom.
Maeve K LalorNational Infection Service, Public Health England.
Allan BennettNational Infection Service, Public Health England.
James WalkerNational Infection Service, Public Health England.
Alicia YeapNational Infection Service, Public Health England.
Antonio Isidro Carrion MartinNational Infection Service, Public Health England.
Gayle DolanNational Infection Service, Public Health England.
Sonia BhattNational Infection Service, Public Health England.
Andrew SkingsleyNational Infection Service, Public Health England.
André CharlettNational Infection Service, Public Health England.
David PearceNational Infection Service, Public Health England.
Katherine RussellNational Infection Service, Public Health England.
Simon KendallSouth Tees Hospitals Foundation NHS Trust, Middlesbrough.
Andrew A KleinPapworth Hospital NHS Foundation Trust, Cambridge.
Stephen RobinsRoyal Wolverhampton NHS Trust, Wolverhampton.
Silke SchelenzRoyal Brompton and Harefield NHS Foundation Trust, London.
William NewsholmeGuy's and St Thomas' NHS Foundation Trust, and.
Stephanie ThomasUniversity Hospital South Manchester NHS Foundation Trust, Manchester.
Tim CollynsLeeds Teaching Hospitals NHS Trust, Leeds, and.
Eleri DaviesPublic Health Wales NHS Trust, Cardiff.
Jim McMenaminVaccine Preventable Diseases, Health Protection Scotland, Glasgow, and.
Lorraine DohertyHealth Protection Service, Public Health Agency Northern Ireland, Belfast, United Kingdom.
Tim E A PetoNuffield Department of Medicine, University of Oxford.
Derrick CrookNational Infection Service, Public Health England.
Maria ZambonNational Infection Service, Public Health England.
Nick PhinNational Infection Service, Public Health England.

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundAn urgent UK investigation was launched to assess risk of invasive Mycobacterium chimaera infection in cardiothoracic surgery and a possible association with cardiopulmonary bypass heater-cooler units following alerts in Switzerland and The Netherlands.

methodsParallel investigations were pursued: (1) identification of cardiopulmonary bypass-associated M. chimaera infection through national laboratory and hospital admissions data linkage; (2) cohort study to assess patient risk; (3) microbiological and aerobiological investigations of heater-coolers in situ and under controlled laboratory conditions; and (4) whole-genome sequencing of clinical and environmental isolates.

resultsEighteen probable cases of cardiopulmonary bypass-associated M. chimaera infection were identified; all except one occurred in adults. Patients had undergone valve replacement in 11 hospitals between 2007 and 2015, a median of 19 months prior to onset (range, 3 months to 5 years). Risk to patients increased after 2010 from <0.2 to 1.65 per 10000 person-years in 2013, a 9-fold rise for infections within 2 years of surgery (rate ratio, 9.08 [95% CI, 1.81-87.76]). Endocarditis was the most common presentation (n = 11). To date, 9 patients have died. Investigations identified aerosol release through breaches in heater-cooler tanks. Mycobacterium chimaera and other pathogens were recovered from water and air samples. Phylogenetic analysis found close clustering of strains from probable cases.

conclusionsWe identified low but escalating risk of severe M. chimaera infection associated with heater-coolers with cases in a quarter of cardiothoracic centers. Our investigations strengthen etiological evidence for the role of heater-coolers in transmission and raise the possibility of an ongoing, international point-source outbreak. Active management of heater-coolers and heightened clinical awareness are imperative given the consequences of infection.

Indexed as

Equipment ContaminationAdultAgedAged, 80 and overAir MicrobiologyCardiopulmonary BypassChildCohort StudiesFemaleHumansMaleMiddle AgedMycobacterium Infections, NontuberculousNontuberculous MycobacteriaRetrospective StudiesRisk Factorsaerosol releasecardiac surgical procedures.disease outbreaksequipment contaminationnontuberculous mycobacteria

Identifiers

PMID27927870
PMCPMC5881635

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.